XML 49 R24.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2025
Stockholders’ Equity [Abstract]  
Schedule of Stock Option Activity

The following table summarizes stock option activity during the nine months ended September 30, 2025:

 

(in thousands, except share and per share amounts)  Number of
Shares
   Weighted-
average
Exercise
Price
   Weighted-
average
Remaining
Contractual
Term
(years)
   Aggregate
Intrinsic
Value
 
Outstanding at January 1, 2025   7,203,307   $8.29    6.49   $1,218 
Options granted   100,000   $7.88    10.0    
-
 
Options exercised   
-
   $
-
    -    
-
 
Options cancelled   (107,965)  $7.50    -    
-
 
Outstanding at September 30, 2025   7,195,342   $8.29    5.80   $
-
 
Exercisable at September 30, 2025   5,379,014   $8.80    4.81   $
-
 
Schedule of Stock-Based Compensation Expense

The following summarizes the components of stock-based compensation expense in the consolidated statements of operations for the nine months ended September 30, 2025 and 2024 respectively:

 

(in thousands)  Three Months
Ended
September 30,
2025
   Three Months
Ended
September 30,
2024
   Nine Months
Ended
September 30,
2025
   Nine Months
Ended
September 30,
2024
 
Research and development  $1,363   $677   $2,820   $2,375 
General and administrative   1,621    1,042    3,774    3,473 
Total  $2,984   $1,719   $6,594   $5,848